You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

allogenic transplantation

Showing 1 - 25 of 7,641
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Thrombotic Disorder Trial (N-acetyl-cysteine, Busulfan, Cytarabine)

Not yet recruiting
  • Thrombotic Disorder
  • (no location specified)
Jun 8, 2023

GVHD Trial in Nantes (drug, radiation, other)

Terminated
  • Graft Versus Host Disease
  • Nantes, France
    Nantes Uh
Jul 13, 2022

End Stage Liver Disease Trial in Boston (LYG-LIV0001)

Enrolling by invitation
  • End Stage Liver Disease
  • LYG-LIV0001
  • Boston, Massachusetts
  • +1 more
Jan 30, 2023

Refractory Idiopathic Aplastic Anemia, Haploidentical Allogeneic Hematopoietic Stem Cell Transplantation Trial (Allogenic

Not yet recruiting
  • Refractory Idiopathic Aplastic Anemia
  • Haploidentical Allogeneic Hematopoietic Stem Cell Transplantation
  • Allogenic transplantation
  • (no location specified)
Nov 8, 2021

Acute Leukemia, Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia Trial (drug, radiation, procedure)

Not yet recruiting
  • Acute Leukemia
  • +4 more
  • (no location specified)
Oct 18, 2022

Influence of Timing PTCy in AlloSCT

Not yet recruiting
  • Cyclophosphamide Toxicity
  • Allogenic Haematopoetic Transplantation
  • (no location specified)
Jun 6, 2023

MDS Trial in Bari, Rozzano (bone marrow withdrawal)

Recruiting
  • Myelodysplastic Syndromes
  • bone marrow withdrawal
  • Bari, Italy
  • +6 more
Oct 10, 2022

Multiple Myeloma, Refractory Multiple Myeloma Trial (procedure, drug, radiation)

Withdrawn
  • Multiple Myeloma
  • Refractory Multiple Myeloma
  • nonmyeloablative allogeneic hematopoietic stem cell transplantation
  • +7 more
  • (no location specified)
Jan 4, 2023

Diabetes, Type 1 Trial in Chicago (Allogenic islet cells (human, U. Chicago), Intraportal infusion of islet cells)

Recruiting
  • Diabetes Mellitus, Type 1
  • Allogenic islet cells (human, U. Chicago)
  • Intraportal infusion of islet cells
  • Chicago, Illinois
    The University of Chicago
Nov 7, 2022

Allogenic Stem Cell Transplantation Trial (SAR445419)

Not yet recruiting
  • Allogenic Stem Cell Transplantation
  • (no location specified)
Feb 13, 2023

Hematopoietic Cell Transplantation Trial in Boston (Care.Coach)

Recruiting
  • Hematopoietic Cell Transplantation
  • Care.Coach
  • Boston, Massachusetts
  • +1 more
Nov 21, 2022

Burn Wound, Second- or Third-degree Burn Trial in Caracas (Implantation of allogeneic MSCs on burn wounds)

Enrolling by invitation
  • Burn Wound
  • Second- or Third-degree Burn
  • Implantation of allogeneic MSCs on burn wounds
  • Caracas, Miranda, Venezuela
    Instituto Venezolano de Investigaciones Cientificas
Oct 23, 2023

Resistance Bacterial Trial in Ghent (Allogenic FMT, Autologous FMT)

Recruiting
  • Resistance Bacterial
  • Allogenic FMT
  • Autologous FMT
  • Ghent, Oost-Vlaanderen, Belgium
    Ghent University Hospital
Dec 28, 2022

Parkinson Disease Trial in San José (PASC transplantation (25 million PASCs/patient), Control)

Active, not recruiting
  • Parkinson Disease
  • PASC transplantation (25 million PASCs/patient)
  • Control
  • San José, Costa Rica
  • +1 more
Nov 28, 2023

Untreated Myelodysplastic Syndrome Trial in France (Onureg + Venetoclax)

Not yet recruiting
  • Untreated Myelodysplastic Syndrome
  • Onureg + Venetoclax
  • Angers, France
  • +9 more
Mar 13, 2023

Mitochondrial Diseases, Pearson Syndrome Trial in Ramat Gan (MNV-201)

Recruiting
  • Mitochondrial Diseases
  • Pearson Syndrome
  • MNV-201
  • Ramat Gan, Israel
    Sheba Medical Center
Aug 24, 2023

Diabetes, Type 1 Trial in Duarte (Allogenic Human Islet Cells, Gastrin 17)

Recruiting
  • Diabetes Mellitus, Type 1
  • Allogenic Human Islet Cells
  • Gastrin 17
  • Duarte, California
    City of Hope Medical Center
Feb 16, 2022

Poor Graft Function Trial (Decitabine, Granulocyte Colony-Stimulating Factor, Thrombopoietin Receptor Agonist)

Not yet recruiting
  • Poor Graft Function
  • (no location specified)
Jun 8, 2023

Graft-versus-host Disease Trial in New York (Cyclophosphamide, Abatacept, Bortezomib)

Recruiting
  • Graft-versus-host Disease
  • New York, New York
    NYU Langone Health
Mar 24, 2022

Cytomegalovirus, Adenovirus Trial in Memphis (VST infusion, CliniMACS)

Not yet recruiting
  • Cytomegalovirus
  • Adenovirus
  • VST infusion
  • CliniMACS
  • Memphis, Tennessee
    St . Jude Children's Research Hospital
Jan 9, 2023

ST Elevation Myocardial Infarction Trial in Jakarta Pusat (Umbilical Cord Mesenchymal Stem Cell transplantation)

Not yet recruiting
  • ST Elevation Myocardial Infarction
  • Umbilical Cord Mesenchymal Stem Cell transplantation
  • Jakarta Pusat, DKI Jakarta, Indonesia
    Cipto Mangunkusumo Hospital
Jul 5, 2023

Myelofibrosis Trial (Allogenic transplantation transplantation)

Not yet recruiting
  • Myelofibrosis
  • Allogenic transplantation transplantation
  • (no location specified)
Jan 24, 2021

Poor Graft Function Trial (decitabine, umbilical cord blood, Granulocyte-colony stimulating factor)

Not yet recruiting
  • Poor Graft Function
  • (no location specified)
Dec 29, 2022

MDS, AML Trial in France (ASTX727, Donor Lymphocyte Infusions)

Recruiting
  • MDS
  • AML
  • Amiens, France
  • +15 more
Jul 21, 2022

Adult Acute Lymphoblastic Leukemia in Remission, Adult Acute Myeloid Leukemia in Remission, Adult Acute Myeloid Leukemia With

Active, not recruiting
  • Adult Acute Lymphoblastic Leukemia in Remission
  • +14 more
  • radiation therapy
  • +8 more
  • Columbus, Ohio
    Arthur G. James Cancer Hospital and Solove Research Institute at
Oct 7, 2022